17 Aug 2026Open access
Development of Phenoxyacetic Acid Hybrids With COX‐2 Inhibitory Activity as Potential Anti‐Neuroinflammatory AgentsPublisher siteDrug Development Research, Neuroscience and Neuropharmacology Research
UniversitiesHatem A. Abdel‐Aziz
Active, last published 2026
In synthesis and biological activity
Hatem A.
Abdel‐Aziz
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
National Research Centre
Claim Your Profile57
H-index
8.2k
Citations
Hatem has not officially claimed their profile. If you are Hatem, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
atem A. Abdel‐Aziz is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Hatem's work has been cited 8,160 times across 10 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×185Synthesis and Characterization of Heterocyclic Compounds×74Synthesis and Biological Evaluation×61Crystal structures of chemical compounds×47Enzyme function and inhibition×46
04 · Where I am
Affiliations
Affiliation on published researchNational Research CentreDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
95 works18 Dec 2025Open access
Discovery of enaminone-linked benzofuran derivatives as dual VEGFR-2/hCA IX inhibitors exhibiting hypoxia-mediated chemosensitizationPublisher siteRSC Medicinal Chemistry
17 Dec 20255cites
Rational Design of Triazole Hydrazide Derivatives With Imidazo[2,1‐ <i>b</i> ]thiazole Scaffolds as Targeted EGFR Inhibitors in NSCLCPublisher siteDrug Development Research, Click Chemistry and Applications
20 Nov 2025Open access
Development of New Pyrazolo [3,4-b]Pyridine Derivatives as Potent Anti-Leukemic Agents and Topoisomerase IIα Inhibitors with Broad-Spectrum CytotoxicityPublisher sitePharmaceuticals
9 Oct 2025
Harnessing benzofuran scaffolds: A journey through design, synthesis, and biological discovery toward safer anti-diabetic and anti-oxidant candidatesPublisher siteEuropean Journal of Medicinal Chemistry, Click Chemistry and Applications
24 Sept 20252cites
Design, Synthesis, and 2D QSAR Analysis of Some Novel Pyrazolo[1,5‐a]pyrimidine Derivatives as Pim‐1 Kinase Inhibitors for the Treatment of MCF‐7 Breast CancerPublisher siteDrug Development Research, Cancer Mechanisms and Therapy
22 Aug 20257cites
Design, synthesis and biological evaluation of triazolo[1,5-a]pyrimidine derivatives as new antiproliferative agents with multikinase inhibitory activityPublisher siteBioorganic Chemistry, Quinazolinone synthesis and applications
11 Aug 2025Open access
2-(Piperidin-1-yl)-N-(4-sulfamoylphenyl)acetamide derivatives as novel inhibitors of cancer-associated carbonic anhydrase isoforms IX and XIIPublisher siteInternational Journal of Biological Macromolecules, Enzyme function and inhibition
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Hatem?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you